期刊文献+

药物作用的遗传差异 被引量:2

下载PDF
导出
摘要  目的:临床上药物遗传对药物的个体差异起着十分重要的作用。方法:查阅近几年文献。结果:药物Ⅰ相和Ⅱ相代谢中不乏存在遗传引起药物个体差异的现象,如细胞色素 P450 酶的遗传多态性使同样药物、同样剂量的治疗对不同个体产生不同药物反应,因而了解其机理并开发出临床上可行的检测方法有利于临床实行个体化治疗。结论:随着人类基因组工程的进展,遗传基因编码的药物代谢酶、转运蛋白、药物受体等会逐步了解,使临床医生对每个患者能选择更为合适的药物、更为合适的剂量治疗疾病。
作者 施安国
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2005年第2期165-167,共3页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献13

  • 1Evans WE, McLeod HL. Pharmacogenomic-drug disposition.drug target, and side effects[J]. N Eng J Meal, 2003, 348 (8) : 538.
  • 2Wilkinson GR. Pharmacokinetics. Goodman & Gilman's the pharmacological basis of therapeutics[M]. 10th ed. New York:McGraw Hill,2001,3.
  • 3施安国.CYP2D6基因与药物代谢[J].中国新药与临床杂志,2003,22(8):491-494. 被引量:4
  • 4Ingelman-Sundberg M, Evans WE. Unravelling the functional genomics of the human CYP2D6 gene locus[J]. Pharmacogenetics,2001,11:553.
  • 5Dalen P,Dahl ML,Ruiz MB,et al. 10-Hydroxylation of nortriptyline in white persons with 0,1,2,3,and 13 functional CYP2D6 gene[J]. Clin Pharmacol Ther, 1998,63(4):444.
  • 6Kuehl P, Zhang J, I.in Y, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression[J]. Nat Genet,2001,27(4) :383.
  • 7Raida M, Schwabe W, Hausler P,et al. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD)gene with in the 5 '-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls[J]. Clin Cancer Res,2001,7:2832.
  • 8Weinsshilboum RM, Otterness DM, Szumlanski CL. Methylation Pharmacogenetics : catechol O-methyltransferase, and histamine N-methyltransferase[J]. Annu Rev Pharmacol Toxicol,1999,39:19.
  • 9Collie-Duguid ESR,Pritchard SC,Powrie RH,et al. The frequencyand distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations[J]. Pharmacogenetics, 1999,9:37.
  • 10Hall D, Ybazeta G, Destro-Bisol G, et al. Variability at the uridine diphosphate glucuronosyltranferase 1A1 promoter in human populations and primates[J]. Pharmacogenetics. 1999,9 : 591.

二级参考文献21

  • 1BERTILSSON L, DAHL M L. Polymorphic drug oxidation.Relevance to the treatment of psychiatric disorders [ J ]. J CNS Drugs, 1996,5(2) :200-223.
  • 2MEYER UA. Pharmacogenetics and adverse drug reaction[ J ].Lancet, 2000, 356(9242) : 1667-1671.
  • 3HEIM HM, MEYER UA. Evolution of a highly polymorphic human cytochrome P-450 gene cluster: CYP2D6 [J ]. Genomics,1992,14(1) :49-58.
  • 4WENNERHOLM A, JOHANSSON I, MASSELE AY, et al.Decreased capacity for debrisoquine metabolism among black Tanzanians. Analyses of the CYP2D6 genotype and phenotype [ J ].Pharmacogenetics, 1999,9(6) :707-714.
  • 5GRIESE EU, ASANTE-POKU S, OFORI-ADJEI D, et al.Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population[J ]. Pharmacogenetics, 1999,9 (6) : 715-723.
  • 6BERTILSSON L, DAHL ML,SJOQVIST F,et al. Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine[ J ]. Lancet, 1993,341 (8836) : 63.
  • 7BERNAL ML, SINUES B, JOHANSSON I, et al. Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 gene associated with ultrarapid metabolism of debrisoquine[J]. Pharmacogenetics, 1999,9(5):657-660.
  • 8SCORDO MG, SPINA E, FACCIOLA G, et al. Cytochrome P-450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxy risperidone [ J ]. Psychopharmacology, 1999,147 (2) :300-305.
  • 9MeLELLAN RA, OSCARSON M, SEIDEGARD JE, et al. Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians[J]. Pharmacogenetics, 1997,7(2) : 187-191.
  • 10DALEN P, DAHL ML, RUIZ ML, et al. 10-Hydroxylation of nortriptyline in Caucasians with 0, 1, 2, 3 and 13 functional CYP2D6 genes[J]. Clin Pharmacol Ther, 1998,63(4) :444-452.

共引文献3

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部